Breathing Labs
Home
How To Start
Products
Breathing+ Package
Toys Package
Q&A
Login

PULMONARY DISEASES

4May

FDA approves world’s first RSV vaccine for older adults

Posted by: admin Categories: PULMONARY DISEASES
Comments Off on FDA approves world’s first RSV vaccine for older adults

The U.S. Food and Drug Administration (FDA) on Thursday approved the world’s first respiratory syncytial virus (RSV) vaccine for older adults. AREXVY, produced by biopharma company GSK, is a single-shot vaccine for adults 60-years-old and older. In a clinical trial, AREXVY was 94% effective at preventing severe RSV in seniors. “Very exciting. I don’t think […]

Read more
Tags:
4May

What is the link between asthma and lung cancer? Understanding the connection

Posted by: admin Categories: PULMONARY DISEASES
Comments Off on What is the link between asthma and lung cancer? Understanding the connection

First Published May 3, 2023, 4:29 PM IST Asthma is a chronic respiratory condition affecting millions of people worldwide. It is a condition that makes breathing challenging by causing the lungs’ airways to swell and inflame. People who have asthma have sensitive airways that respond to allergens, irritants, and physical activity as triggers.  These triggers […]

Read more
Tags:
4May

Cystic Fibrosis Drug Market to Grow at 24.5% CAGR and Reach USD

Posted by: admin Categories: PULMONARY DISEASES
Comments Off on Cystic Fibrosis Drug Market to Grow at 24.5% CAGR and Reach USD

Cystic Fibrosis Drug Market Size The global Cystic Fibrosis Drug Market size was USD 8.85 billion in 2021, and it is projected to achieve a revenue CAGR of 24.5% during the forecast period. The primary drivers of this growth are the introduction of new therapeutics and technologies for treatment. The demand for bronchodilator drugs is […]

Read more
Tags:
4May

World’s 1st RSV vaccine approved in U.S. for adults aged 60 and up

Posted by: admin Categories: PULMONARY DISEASES
Comments Off on World’s 1st RSV vaccine approved in U.S. for adults aged 60 and up

The world’s first vaccine for respiratory syncytial virus (RSV) was approved by the U.S. Food and Drug Administration (FDA) on Wednesday. The Arexvy vaccine, made by GlaxoSmithKline (GSK), was approved for the prevention of lower respiratory tract disease caused by RSV in individuals 60 years of age and older, according to an FDA release. “Older adults, […]

Read more
Tags:
4May

US drug regulator approves world’s first RSV vaccine

Posted by: admin Categories: PULMONARY DISEASES
Comments Off on US drug regulator approves world’s first RSV vaccine

An RSV cell The US Food and Drug Administration has approved a vaccine against respiratory syncytial virus (RSV) – an illness that kills thousands of Americans each year. The vaccine still needs approval from the US Centers for Disease Control and Prevention before it can be rolled out to the public. Officials say the vaccine, […]

Read more
Tags:
4May

Breathing Disorders & Treatment Market Major Strategies Adopted By Leading Market Companies

Posted by: admin Categories: PULMONARY DISEASES
Comments Off on Breathing Disorders & Treatment Market Major Strategies Adopted By Leading Market Companies

With a focus on Global Breathing Disorders & Treatment Market and general market expansion and trends for 2022-2030, by Marketreports.info reports on the main elements and current market trends. There is a projected income for Breathing Disorders & Treatment in the period 2022-2030 (2022 is used as a starting point and 2030 as a projection […]

Read more
Tags:
4May

Cycling is down nearly a quarter since coronavirus peak

Posted by: admin Categories: PULMONARY DISEASES
Comments Off on Cycling is down nearly a quarter since coronavirus peak

C ycling on main roads in England has fallen by nearly a quarter from the peak recorded during coronavirus restrictions, Department for Transport (DfT) figures show. The decline has sparked fears the Government will fail to hit targets for increasing cycling activity. DfT data demonstrates the surge in cycling – when Covid restrictions affected travel […]

Read more
Tags:
4May

Monovalent mRNA COVID-19 vaccines provide durable protection against critical outcomes

Posted by: admin Categories: PULMONARY DISEASES
Comments Off on Monovalent mRNA COVID-19 vaccines provide durable protection against critical outcomes

In a recent Morbidity and Mortality Weekly Report (MMWR) published on the United States Center for Disease Control and Prevention (US-CDC) website, researchers evaluated the durability of protection conferred by monovalent messenger ribonucleic acid (mRNA) coronavirus disease 2019 (COVID-19) vaccines against invasive mechanical ventilation (IMV) and in-hospital death during the period of the predominance of […]

Read more
Tags:
3May

Study examines the reinfection of SARS-CoV-2 variants in children

Posted by: admin Categories: PULMONARY DISEASES
Comments Off on Study examines the reinfection of SARS-CoV-2 variants in children

In a recent study published in the Journal of the Pediatric Infectious Diseases Society, researchers characterized the children with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection, determined the number of reinfections, and characterized the intervals between two infections in the patient population. Study: SARS-CoV-2 Reinfection With Different SARS-CoV-2 Variants in Children, Ohio, United States. Image […]

Read more
Tags:
3May

Throw your probiotic supplements away and do these 3 things instead, a gut health expert says

Posted by: admin Categories: PULMONARY DISEASES
Comments Off on Throw your probiotic supplements away and do these 3 things instead, a gut health expert says

Fruits and vegetables “feed” the tiny bacteria in digestive tract, which improves overall gut health.Crystal Cox/Business Insider A gastroenterologist shared three ways to improve gut health. Exercise improves the environment in the gut to allow for “good” bacteria to flourish. Probiotic supplements don’t address the underlying factors that contribute to poor gut health. Put the […]

Read more
Tags:
3May

Tune Into the Life You Want Class on Breathwork and Transformation

Posted by: admin Categories: PULMONARY DISEASES
Comments Off on Tune Into the Life You Want Class on Breathwork and Transformation

Breathing—this biological function keeps us alive, yet it’s so automatic we often forget its importance, and its profound healing powers. That’s why Oprah Daily’s next “The Life You Want” curriculum is devoted to breathwork. On Wednesday, May 10, at 4 p.m. ET, we’re releasing a series of instructional videos and articles that will teach you […]

Read more
Tags:
3May

Gasping for air post covid? Could be asthma

Posted by: admin Categories: PULMONARY DISEASES
Comments Off on Gasping for air post covid? Could be asthma

City doctors see increase in number of breakthrough lung infections after covid-19, causing coughing fits, shortness of breath among citizens Covid cases have been a worrying factor for the last three years. However, the doctors in the city say that there has been a spike in asthma cases post covid. Dr Sunil Kumar K, Lead […]

Read more
Tags:
3May

COPD Drug Delivery Devices Market to grow at a CAGR of 4 by the end

Posted by: admin Categories: PULMONARY DISEASES
Comments Off on COPD Drug Delivery Devices Market to grow at a CAGR of 4 by the end

The global COPD Drug Delivery Devices market is estimated to attain a valuation of US$ 11 Bn by the end of 2027, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 4% during the forecast period, 2019-2027. The key objective of […]

Read more
Tags:
3May

Parents charged with murder of daughter in Montgomery County

Posted by: admin Categories: PULMONARY DISEASES
Comments Off on Parents charged with murder of daughter in Montgomery County

MONTGOMERY COUNTY — Two parents are facing murder charges after their daughter died in their care. On Tuesday officers were called to the 9400 block of Quill Place for reports of a person not breathing. When they arrived they spoke with the parents, 40-year-old Cynthia Moore and 45-year-old Dominique Moore. The mother told police their […]

Read more
Tags:
3May

First Respiratory Syncytial Virus Vaccine Approved by FDA

Posted by: admin Categories: PULMONARY DISEASES
Comments Off on First Respiratory Syncytial Virus Vaccine Approved by FDA

The FDA has approved GSK’s Arexvy for use in the United States,1 making it the first vaccine approved for use in older adults (≥60 years) to prevent lower respiratory tract disease (LRTD) associated with respiratory syncytial virus (RSV). “Older adults, in particular those with underlying health conditions, such as heart or lung disease or weakened […]

Read more
Tags:
3May

COVID-19 Impact on Veterinary Breathing Circuits Market Share, Size, Trends and Growth 2022 to 2031

Posted by: admin Categories: PULMONARY DISEASES
Comments Off on COVID-19 Impact on Veterinary Breathing Circuits Market Share, Size, Trends and Growth 2022 to 2031

With a focus on Global Veterinary Breathing Circuits Market and general market expansion and trends for 2022-2030, by Marketreports.info reports on the main elements and current market trends. There is a projected income for Veterinary Breathing Circuits in the period 2022-2030 (2022 is used as a starting point and 2030 as a projection period). In […]

Read more
Tags:
3May

US FDA approves GSK’s Arexvy, the world’s first respiratory syncytial virus (RSV) vaccine for older adults

Posted by: admin Categories: PULMONARY DISEASES
Comments Off on US FDA approves GSK’s Arexvy, the world’s first respiratory syncytial virus (RSV) vaccine for older adults

Ground-breaking approval enables adults aged 60 years and older to be protected from RSV disease for the first time The approval is based on data from the positive pivotal AReSVi-006 phase III trial that showed exceptional efficacy in older adults, including those with underlying medical conditions, and in those with severe RSV disease US launch […]

Read more
Tags:
3May

FDA Approves GSK’s Arexvy as the World’s First RSV Vaccine for Older Adults

Posted by: admin Categories: PULMONARY DISEASES
Comments Off on FDA Approves GSK’s Arexvy as the World’s First RSV Vaccine for Older Adults

Today, the US Food and Drug Administration (FDA) approved GSK’s adjuvanted respiratory syncytial virus (RSV) vaccine Arexvy for older adults. Arexvy (RSVPreF3 +AS01E) was approved to prevent lower respiratory tract disease (LRTD) caused by RSV in adults 60 years and older. With this authorization, announced on its Prescription Drug User Fee Act (PDUFA) date of […]

Read more
Tags:
3May

Ravulizumab Fails to Improve Outcomes in Ventilated Patients With Severe COVID-19

Posted by: admin Categories: PULMONARY DISEASES
Comments Off on Ravulizumab Fails to Improve Outcomes in Ventilated Patients With Severe COVID-19

Ravulizumab as an add-on for best supportive care (BSC) for COVID-19 failed to improve survival or secondary outcomes in hospitalized adults with acute lung injury, severe pneumonia, or acute respiratory distress syndrome (ARDS) who were also receiving either invasive or noninvasive mechanical ventilation, according to study findings published in The Lancet Respiratory Medicine. COVID-19 severity […]

Read more
Tags:
3May

More asthma sufferers live in areas with high levels of pollution

Posted by: admin Categories: PULMONARY DISEASES
Comments Off on More asthma sufferers live in areas with high levels of pollution

The percentage of people with asthma is higher in cities with significantly higher levels of air pollution, according to the Maccabi KSM Research and Innovation Center. Maccabi is Israel’s second-largest health fund, serving 2.7 million people, about 25% of the population. The World Health Organization classifies asthma as a non-communicable disease that affects children and […]

Read more
Tags:
« Older posts
Newer posts »